Covid-19Ro. More than 1,400 new cases of Covid-19 and 107 related deaths, of which 6 from before the current reference timeframe, have been reported in Romania today. The National Committee for Emergency Situations approved on Monday evening the decision on quarantine rules for those who enter Romania, against the current background created by the spread of the Omicron variant in Europe. The measures come in force on Friday, at midnight, and will stay in place until January 8th. According to the Committee, people traveling to Romania from green or yellow areas and have not been vaccinated, cannot show a negative PCR test or have not had the disease in the past 80 days will be quarantined for 14 days. The same measures apply to those who come from red zones and cannot provide the evidence mentioned above. If, however, travelers coming from the countries on the red list have a negative PCR test, they will be quarantined only for 10 days.Brussels. The Romanian Minister of Health, Alexandr
gov ie - Minister for Health meets EU partners to discuss COVID-19 response and wider health cooperation
gov.ie - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from gov.ie Daily Mail and Mail on Sunday newspapers.
Janssen recommends storing vaccine supplies until EMA recommendation next week
imt.ie - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from imt.ie Daily Mail and Mail on Sunday newspapers.
© In-Cyprus 2021 EMA continues to monitor very rare blood clots with low blood platelets that occurred after vaccination with Vaxzevria (formerly COVID-19 Vaccine AstraZeneca). In line with a request from the EU’s Commissioner for Health and Food Safety following a meeting of EU Health Ministers, EMA is undertaking a review of vaccination data and data on disease epidemiology (including infection rates, hospitalisations, morbidity and mortality). The review by EMA’s human medicines committee (CHMP) will enable authorities to put the risks of Vaxzevria into the context of the benefits of ongoing vaccination.